Zivo Bioscience Probability of Future Stock Price Finishing Under 3.05

ZIVODelisted Stock  USD 1.81  0.01  0.55%   
Zivo Bioscience's future price is the expected price of Zivo Bioscience instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Zivo Bioscience performance during a given time horizon utilizing its historical volatility. Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
  
Please specify Zivo Bioscience's target price for which you would like Zivo Bioscience odds to be computed.

Zivo Bioscience Target Price Odds to finish below 3.05

The tendency of Zivo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 3.05  after 90 days
 1.81 90 days 3.05 
about 87.28
Based on a normal probability distribution, the odds of Zivo Bioscience to stay under $ 3.05  after 90 days from now is about 87.28 (This Zivo Bioscience probability density function shows the probability of Zivo Stock to fall within a particular range of prices over 90 days) . Probability of Zivo Bioscience price to stay between its current price of $ 1.81  and $ 3.05  at the end of the 90-day period is about 86.52 .
Given the investment horizon of 90 days Zivo Bioscience has a beta of 0.18. This usually means as returns on the market go up, Zivo Bioscience average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Zivo Bioscience will be expected to be much smaller as well. Additionally Zivo Bioscience has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Zivo Bioscience Price Density   
       Price  

Predictive Modules for Zivo Bioscience

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zivo Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Zivo Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.811.811.81
Details
Intrinsic
Valuation
LowRealHigh
1.721.721.99
Details
Naive
Forecast
LowNextHigh
1.641.641.64
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.672.212.75
Details

Zivo Bioscience Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Zivo Bioscience is not an exception. The market had few large corrections towards the Zivo Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Zivo Bioscience, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Zivo Bioscience within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.65
β
Beta against Dow Jones0.18
σ
Overall volatility
0.35
Ir
Information ratio -0.15

Zivo Bioscience Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Zivo Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Zivo Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Zivo Bioscience is not yet fully synchronised with the market data
Zivo Bioscience may become a speculative penny stock
Zivo Bioscience has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (8.75 M) with profit before overhead, payroll, taxes, and interest of 20 K.
Zivo Bioscience currently holds about 5.08 M in cash with (7.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54.
Roughly 25.0% of the company outstanding shares are owned by insiders

Zivo Bioscience Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Zivo Stock often depends not only on the future outlook of the current and potential Zivo Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zivo Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.6 M
Cash And Short Term Investments1.8 M

Zivo Bioscience Technical Analysis

Zivo Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. Zivo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Zivo Bioscience. In general, you should focus on analyzing Zivo Stock price patterns and their correlations with different microeconomic environments and drivers.

Zivo Bioscience Predictive Forecast Models

Zivo Bioscience's time-series forecasting models is one of many Zivo Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Zivo Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Zivo Bioscience

Checking the ongoing alerts about Zivo Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Zivo Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Zivo Bioscience is not yet fully synchronised with the market data
Zivo Bioscience may become a speculative penny stock
Zivo Bioscience has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (8.75 M) with profit before overhead, payroll, taxes, and interest of 20 K.
Zivo Bioscience currently holds about 5.08 M in cash with (7.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54.
Roughly 25.0% of the company outstanding shares are owned by insiders
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in Zivo Stock

If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios